Reply to: "Liver-adipose tissue crosstalk in nonalcoholic fatty liver disease: the emerging role of remnant cholesterol": "BAT activation might improve NAFLD in patients, but this might require developing and/or maintaining functionally relevant levels of BAT mass."
J Hepatol. 2024 Mar;80(3):e112-e114.
doi: 10.1016/j.jhep.2023.10.027.
Epub 2023 Oct 26.
1 Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Medical Physiology, Graduate School of Medicine; Research Institute of Disaster Medicine, Chiba University, Chiba, Japan.
2 Laboratory of Hepatology, CHROMETA Department, KU Leuven, Leuven, Belgium. Electronic address: hannelie.korf@kuleuven.be.
3 Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Centro de Investigacion Principe Felipe, Valencia, Spain; Cambridge University Nanjing Centre of Technology and Innovation, Nanjing, China. Electronic address: ajv22@cam.ac.uk.